CLINICAL_TRIALS trial_result · 2018-05-08

Clinical Trial Update: A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate [Phase 3]

A Phase 3 rheumatoid arthritis trial evaluating a Lilly-sponsored agent with background methotrexate was terminated. Results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 3 | Status: TERMINATED | Results posted: 2018-05-08